<VariationArchive VariationID="208623" VariationName="NM_000370.3(TTPA):c.19del (p.Gln7fs)" VariationType="Deletion" Accession="VCV000208623" Version="12" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2015-09-14" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="205158" VariationID="208623">
      <GeneList>
        <Gene Symbol="TTPA" FullName="alpha tocopherol transfer protein" GeneID="7274" HGNC_ID="HGNC:12404" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="63058409" stop="63086053" display_start="63058409" display_stop="63086053" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="63972046" stop="63998611" display_start="63972046" display_stop="63998611" Strand="-" />
          </Location>
          <OMIM>600415</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000370.3(TTPA):c.19del (p.Gln7fs)</Name>
      <CanonicalSPDI>NC_000008.11:63086002:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="63086003" stop="63086003" display_start="63086003" display_stop="63086003" variantLength="1" positionVCF="63086002" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="63998562" stop="63998562" display_start="63998562" display_stop="63998562" variantLength="1" positionVCF="63998561" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Q7fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.63998564del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.63998564del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.63086005del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.63086005del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016123.1" sequenceAccession="NG_016123" sequenceVersion="1" change="g.5051del">
            <Expression>NG_016123.1:g.5051del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000370.3" sequenceAccession="NM_000370" sequenceVersion="3" change="c.19del" MANESelect="true">
            <Expression>NM_000370.3:c.19del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000361.1" sequenceAccession="NP_000361" sequenceVersion="1" change="p.Gln7fs">
            <Expression>NP_000361.1:p.Gln7fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000370.3" sequenceAccession="NM_000370" sequenceVersion="3" change="c.19delC" MANESelect="true">
            <Expression>NM_000370.3:c.19delC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA276025" DB="ClinGen" />
        <XRef Type="rs" ID="760014795" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000370.3(TTPA):c.19del (p.Gln7fs) AND Familial isolated deficiency of vitamin E" Accession="RCV000190635" Version="7">
        <ClassifiedConditionList TraitSetID="6513">
          <ClassifiedCondition DB="MedGen" ID="C1848533">Familial isolated deficiency of vitamin E</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-06" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000370.3(TTPA):c.19del (p.Gln7fs) AND not provided" Accession="RCV001047609" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-06" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-09-14" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26068213</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9463307</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6513" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6113" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ataxia with vitamin E deficiency</ElementValue>
                <XRef ID="Ataxia+with+Vitamin+E+Deficiency/639" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia with isolated vitamin E deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial isolated deficiency of vitamin E</ElementValue>
                <XRef ID="MONDO:0010188" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Friedreich-like ataxia with selective vitamin E deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AVED</ElementValue>
                <XRef Type="MIM" ID="277460" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8595" />
                <XRef ID="8595" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Ataxia with vitamin E deficiency (AVED) generally manifests in late childhood or early teens between ages five and 15 years. The first symptoms include progressive ataxia, clumsiness of the hands, loss of proprioception, and areflexia. Other features often observed are dysdiadochokinesia, dysarthria, positive Romberg sign, head titubation, decreased visual acuity, and positive Babinski sign. The phenotype and disease severity vary widely among families with different pathogenic variants; age of onset and disease course are more uniform within a given family, but symptoms and disease severity can vary even among sibs.</Attribute>
                <XRef ID="NBK1241" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301419</ID>
                <ID Source="BookShelf">NBK1241</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/ENS, 2014">
                <ID Source="PubMed">24418350</ID>
              </Citation>
              <XRef ID="96" DB="Orphanet" />
              <XRef ID="C1848533" DB="MedGen" />
              <XRef ID="MONDO:0010188" DB="MONDO" />
              <XRef Type="MIM" ID="277460" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="454423" SubmissionDate="2015-08-18" DateLastUpdated="2015-09-14" DateCreated="2015-09-14">
        <ClinVarSubmissionID localKey="52318721|OMIM:277460" />
        <ClinVarAccession Accession="SCV000245676" DateUpdated="2015-09-14" DateCreated="2015-09-14" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-12-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Gln7SerfsX64 variant in TTPA has not been previously reported in individuals with disease but has been identified in 0.016% (1/6134) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at position 7 and leads to a premature termination codon 64 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Homozygous or compound heterozygous loss of function variants in TTPA have been shown to cause ataxia with isolated vitamin E deficiency. In summary, this variant meets our criteria to be classified as pathogenic for ataxia with isolated vitamin E deficiency in an autosomal recessive manner.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TTPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000370.3:EXON 1</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000370.3:c.19delC</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.63998562del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Ataxia with vitamin E deficiency</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="277460" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-MedSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>CSER-MedSeq</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2376903" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6229548|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001211576" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9463307</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26068213</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gln7Serfs*64) in the TTPA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TTPA are known to be pathogenic (PMID: 9463307, 26068213). This variant is present in population databases (rs760014795, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with TTPA-related conditions. ClinVar contains an entry for this variant (Variation ID: 208623). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TTPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.63998562del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7858305" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000370.3:c.19del|OMIM:277460" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004207490" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000370.3:c.19del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277460" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7858305" TraitType="Disease" MappingType="XRef" MappingValue="277460" MappingRef="OMIM">
        <MedGen CUI="C1848533" Name="Familial isolated deficiency of vitamin E" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="454423" TraitType="Disease" MappingType="Name" MappingValue="Ataxia with vitamin E deficiency" MappingRef="Preferred">
        <MedGen CUI="C1848533" Name="Familial isolated deficiency of vitamin E" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2376903" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

